1. Home
  2. CTSO vs HOLO Comparison

CTSO vs HOLO Comparison

Compare CTSO & HOLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTSO
  • HOLO
  • Stock Information
  • Founded
  • CTSO 1997
  • HOLO 2018
  • Country
  • CTSO United States
  • HOLO China
  • Employees
  • CTSO N/A
  • HOLO N/A
  • Industry
  • CTSO Medical/Dental Instruments
  • HOLO Computer Software: Programming Data Processing
  • Sector
  • CTSO Health Care
  • HOLO Technology
  • Exchange
  • CTSO Nasdaq
  • HOLO Nasdaq
  • Market Cap
  • CTSO 58.6M
  • HOLO 66.3M
  • IPO Year
  • CTSO N/A
  • HOLO N/A
  • Fundamental
  • Price
  • CTSO $0.92
  • HOLO $5.03
  • Analyst Decision
  • CTSO Buy
  • HOLO
  • Analyst Count
  • CTSO 2
  • HOLO 0
  • Target Price
  • CTSO $5.50
  • HOLO N/A
  • AVG Volume (30 Days)
  • CTSO 78.2K
  • HOLO 3.1M
  • Earning Date
  • CTSO 11-06-2025
  • HOLO 01-01-0001
  • Dividend Yield
  • CTSO N/A
  • HOLO N/A
  • EPS Growth
  • CTSO N/A
  • HOLO N/A
  • EPS
  • CTSO N/A
  • HOLO 13.81
  • Revenue
  • CTSO $36,107,520.00
  • HOLO $44,840,587.00
  • Revenue This Year
  • CTSO $11.93
  • HOLO N/A
  • Revenue Next Year
  • CTSO $21.22
  • HOLO N/A
  • P/E Ratio
  • CTSO N/A
  • HOLO $0.35
  • Revenue Growth
  • CTSO 20.18
  • HOLO 37.10
  • 52 Week Low
  • CTSO $0.71
  • HOLO $4.16
  • 52 Week High
  • CTSO $1.61
  • HOLO $370.00
  • Technical
  • Relative Strength Index (RSI)
  • CTSO 45.35
  • HOLO 49.98
  • Support Level
  • CTSO $0.90
  • HOLO $4.50
  • Resistance Level
  • CTSO $0.96
  • HOLO $5.66
  • Average True Range (ATR)
  • CTSO 0.05
  • HOLO 0.35
  • MACD
  • CTSO -0.00
  • HOLO -0.05
  • Stochastic Oscillator
  • CTSO 16.67
  • HOLO 44.05

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About HOLO MicroCloud Hologram Inc.

MicroCloud Hologram Inc, through its subsidiaries, is mainly engaged in holographic Technology. It includes Holographic solutions and Holographic technology services. The company also provides holographic digital twin technology services for customers and has built a holographic digital twin technology resource library. Geographically company is operating in single segment, China.

Share on Social Networks: